Continuing Medical Education (CME) Department Event Listing

1 - 5 of 5

The CAR-T Revolution 3 Years After FDA Approval

Torie CART

Three years after FDA approval of the first CAR-T therapy, Dr. Grupp will review outcomes data and provide an update on advancements and new trials in the field of cancer immunotherapy for patients with relapsed acute lymphoblastic leukemia (ALL).

Date:
Dec 15, 2020 from 5 p.m. - 6:30 p.m. (ET)

Cancer Predisposition and Surveillance in Children and Adolescents

Grayson

During this webinar, we will present the general approach to patients with a possible cancer predisposition syndrome, review a few of the more common cancer surveillance syndromes, and discuss future directions in the field of pediatric cancer predisposition.

Date:
Jan 19, 2021 from 5:30 p.m. - 6:30 p.m. (ET)